


| New Early Breast Cancer Drug Approved by Singapore Health Sciences Authority |
|
NERLYNX (neratinib) now approved in Singapore for HER2+ breast cancer patients following adjuvant trastuzumab-based therapy; NERLYNX is the first therapy in the Specialised Therapeutics' portfolio approved in SE Asia; Five-year follow up data show NERLYNX reduces risk of invasive disease recurrence....
Posted: 2019-12-02 23:00:00
|
If you are a broadcaster or Christian program producer you can schedule a 15 min FREE consultation with an EGR specialist to help you evaluate all possible Int'l broadcasting options.
We will call you back at a number and time of your convenience, and will gladly answer any question that you may have on how to broadcast your Christian message worldwide.